IPSC·Nasdaq·US
Century Therapeutics
Century Therapeutics is a biotechnology company that uses allogeneic pluripotent stem cell therapies to develop cell therapy products for autoimmune diseases, including type 1 diabetes, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, derived from healthy donors for use in any patient, and are built on induced pluripotent stem cells.
Source: SEC 10-K Mar 12, 2026
Recent Activity
Updated Oct 3, 2026
–Century Therapeutics presented nonclinical data on CNTY-813, its iPSC-derived islet cell therapy, at EASD 2026, demonstrating scalable production, in vivo function, and immune evasion.
–The data showed updated progress toward clinical dosing of CNTY-813.
Past updates are part of the Pro plan.
Thematic Position
Relationship Groups
Relationship details are part of the Pro plan.